Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission. .
The infection can be diagnosed through serological testing methods such as Enzyme-linked immunoassay test. Many of the cases of CMV goes undiagnosed in early stage of infection thus the awareness about the infection is most important factor. According to the Centers for Disease Control and Prevention (CDC), in U.S., each year around 150 infants are born with cytomegalovirus infections and few of them have long term health problems.
Cytomegalovirus Infection Market: Drivers and Restraints
sThe key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period.
The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.
To Remain ‘Ahead’ Of Your Competitors, Request For Sample Report Here @ https://www.persistencemarketresearch.com/samples/17356
Cytomegalovirus Infection Market: Segmentation
The global cytomegalovirus infection market is classified on the basis of drug class, infection type distribution channel, and geography.
Based on drug type, the global cytomegalovirus infection market is segmented into the following:
- Cidofovir
- Foscarnet
- Valganciclovir
- Ganciclovir
Based on infection type, the global cytomegalovirus infection market is segmented into the following:
- Retinitis
- Pneumonia
- Gastrointestinal Ulcers
- Encephalitis
- Others (Mouth Ulcers, Pharyngitis, etc.)
Based on distribution channel, the global cytomegalovirus infection market is segmented into the following:
- Hospitals
- Retail Pharmacies
- Online Pharmacies
Cytomegalovirus Infection Market: Overview
Based on product type, the market is segmented into Cidofovir, Foscarnet, Valganciclovir, and Ganciclovir. These are few of the most prescriobed medication for the treatment of cytomegalovirus.
Similarly, based on distribution channel, the market is segmented into, hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies are expected to hold maximum share in the market due to the easy availability of medication and increasing prescription patterns for the treatment of CMV.
Cytomegalovirus Infection Market: Regional Overview
Region wise, the global cytomegalovirus infection market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. The growth of CMV virus is attributed to the increasing awareness regarding the herpes virus and increasing diagnosis rate in developed region such as North America and Europe.
Similarly, the government initiatives for the awareness regarding rate disease, growing healthcare expenditure and escalating disposable income are few of the factors responsible the market growth in Asia-Pacific.
To Receive An Extensive List Of Important Regions, Ask For Toc Here @https://www.persistencemarketresearch.com/toc/17356
Cytomegalovirus Infection Market: Key Players
- F. Hoffmann-La Roche,
- GlaxoSmithKline plc,
- Vical, Inc.,
- AiCuris Anti-infective Cures GmbH,
- ViroPharma,
- Chimerix, Inc.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
For In-depth Competitive Analysis, Pre-Book Report Now @ https://www.persistencemarketresearch.com/checkout/17356
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.